DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Hellio Le Graverand MP, Clemmer RS, Redifer P et al.
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee.
Ann Rheum Dis 2013;
72: 187-195
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.